![Charles Rowland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Rowland
Directeur/Membre du Conseil chez
VIKING THERAPEUTICS, INC.
Fortune : 982 200 $ au 31/05/2026
Profil
Charles A. Rowland is currently Director at Financial Executives International Philadelphia Chapter, Independent Director at Orchard Therapeutics (Europe) Ltd. since 2018, and Independent Director at Viking Therapeutics, Inc. since 2016.
Former roles include Co-Chief Executive Officer, CFO & Executive VP at Endo Pharmaceuticals, Inc. from 2006 to 2008; President, Chief Executive Officer & Director at Aurinia Pharmaceuticals, Inc. from 2016 to 2017; Finance Director at Bristol Myers Squibb Co. from 1985 to 1993; Independent Director at Idenix Pharmaceuticals LLC in 2014; Independent Director at DNIB Unwind, Inc. from 2015 to 2016; Independent Director at Nabriva Therapeutics Plc from 2015 to 2024; Independent Director at Vitae Pharmaceuticals LLC from 2015 to 2016; Independent Director at Generation Bio Co. from 2018 to 2026; Non-Executive Director at Akamis Bio Ltd. from 2017 to 2019; Director at Blueprint Medicines Corp.
from 2015 to 2022; Director at Bind Therapeutics from 2014 to 2016; Independent Non-Executive Director at Orchard Therapeutics Plc from 2018 to 2024; Chief Financial Officer at Biovail Corp.
from 2004 to 2006; Chief Financial Officer & Vice President at Shire ViroPharma, Inc. from 2012 to 2014; Chief Financial Officer, Treasurer & Executive VP at Endo Health Solutions, Inc. from 2006 to 2008; Vice President-Finance & Global Supply at Pharmacia Corp.
from 1998 to 2001; Vice President-Planning & Decision Support at Novartis Pharmaceuticals Corp.
from 1993 to 1998; Member-Supervisory Board at Nabriva Therapeutics GmbH from 2015 to 2017; Chief Financial Officer & Senior Vice President at Biovail Pharmaceuticals LLC in 2006; Chief Operating & Financial Officer at Breakaway Technologies, Inc. in 2004; Chief Financial Officer & Vice President at Viropharma, Inc. from 2008 to 2014.
Education includes an MBA from Rutgers State University of New Jersey in 1991 and an undergraduate degree from St. Joseph's University in 1980.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2026 | 30 000 ( 0,03 % ) | 982 200 $ | 31/05/2026 |
Postes actifs de Charles Rowland
| Sociétés | Poste | Début |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2016 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Directeur/Membre du Conseil | 07/06/2018 |
Financial Executives International Philadelphia Chapter | Directeur/Membre du Conseil | - |
Anciens postes connus de Charles Rowland
| Sociétés | Poste | Fin |
|---|---|---|
| GENERATION BIO CO. | Directeur/Membre du Conseil | 06/02/2026 |
| NABRIVA THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/12/2024 |
| ORCHARD THERAPEUTICS PLC | Directeur/Membre du Conseil | 24/01/2024 |
| BLUEPRINT MEDICINES CORPORATION | Directeur/Membre du Conseil | 01/06/2022 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Directeur/Membre du Conseil | 01/10/2019 |
Formation de Charles Rowland
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical medicines | Health Technology |
Breakaway Technologies, Inc.
 Breakaway Technologies, Inc. Packaged SoftwareTechnology Services Develops analytic and business intelligence software | Technology Services |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Financial Executives International Philadelphia Chapter | |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Viropharma, Inc. |
